v3.26.1
Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)
12 Months Ended
Feb. 12, 2026
Feb. 10, 2025
Oct. 04, 2024
Apr. 15, 2024
Feb. 16, 2023
Dec. 15, 2022
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Feb. 23, 2021
Product Information [Line Items]                    
Accounts receivable             $ 1,128,000 $ 1,613,000    
Advertising expense             $ 590,000 258,000    
Option vesting period             4 years      
Option maximum contractual term             10 years      
Total contributions to the plan             $ 321,000 318,000    
Accrued interest and penalties             0 0    
Unrecognized tax benefits             1,629,000 1,087,000 $ 2,296,000  
Inventories             368,000 207,000    
Inventory finished goods             78,000 203,000    
Assets held for sale             0 0    
Impairment loss on held for sale assets               $ 169,000    
Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]               Gain (Loss) on Disposition of Other Assets    
Cash and cash equivalents with restricted cash             $ 12,919,000 $ 10,336,000 11,132,000  
Common Stock [Member]                    
Product Information [Line Items]                    
Warrants to purchase shares   3,069,926   342,888            
Number of shares issued               611,000    
Subsequent Event [Member] | Pre-Funded Warrant [Member]                    
Product Information [Line Items]                    
Warrants to purchase shares 1,043,478                  
Private Placement [Member] | Common Stock [Member]                    
Product Information [Line Items]                    
Issuance of common stock shares   109,756 37,037 42,373            
Private Placement [Member] | Subsequent Event [Member] | Common Stock [Member]                    
Product Information [Line Items]                    
Issuance of common stock shares 3,482,498                  
Private Placement [Member] | Subsequent Event [Member] | Pre-Funded Warrant [Member]                    
Product Information [Line Items]                    
Warrant to purchase common stock 1,043,478                  
ASU 2023-09 [Member]                    
Product Information [Line Items]                    
Change in accounting principle, accounting standards update, adopted [true false]             true      
Change in accounting principle, accounting standards update, adoption date             Dec. 31, 2025      
Change in accounting principle, accounting standards update, immaterial effect [true false]             true      
Razor Genomics, Inc. [Member]                    
Product Information [Line Items]                    
Equity interest                   25.00%
Razor Stock Purchase Agreement [Member] | Razor Genomics, Inc. [Member]                    
Product Information [Line Items]                    
Equity method investment, number of shares held         1,366,364          
Equity interest         30.00%          
Razor Stock Purchase Agreement [Member] | Razor Genomics, Inc. [Member] | Dragon Scientific LLC [Member]                    
Product Information [Line Items]                    
Number of shares sold           3,188,181        
Percentage of ownership sold         70.00% 70.00%        
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer One [Member]                    
Product Information [Line Items]                    
Concentration risk percentage             100.00% 97.00%    
Accounts Payable [Member] | Customer Concentration Risk [Member] | Customer One [Member]                    
Product Information [Line Items]                    
Concentration risk percentage             50.00% 37.00%    
Accounts Payable [Member] | Customer Concentration Risk [Member] | Customer Two [Member]                    
Product Information [Line Items]                    
Concentration risk percentage             10.00% 28.00%    
Accounts Payable [Member] | Customer Concentration Risk [Member] | Customer Three [Member]                    
Product Information [Line Items]                    
Concentration risk percentage               14.00%    
Laboratory Services [Member]                    
Product Information [Line Items]                    
Accounts receivable             $ 1,100,000 $ 1,600,000 489,000  
Accounts receivable, allowance for credit loss             11,000 16,000 $ 5,000  
Kitted Products [Member]                    
Product Information [Line Items]                    
Accounts receivable             $ 0 $ 0    
Minimum [Member]                    
Product Information [Line Items]                    
Long-lived intangible assets, useful life             1 year      
Maximum [Member]                    
Product Information [Line Items]                    
Long-lived intangible assets, useful life             9 years      
Machinery and Equipment [Member] | Minimum [Member]                    
Product Information [Line Items]                    
Estimated useful life of plant and equipment             3 years      
Machinery and Equipment [Member] | Maximum [Member]                    
Product Information [Line Items]                    
Estimated useful life of plant and equipment             10 years      
Equipment [Member] | Minimum [Member]                    
Product Information [Line Items]                    
Lease term             3 years      
Equipment [Member] | Maximum [Member]                    
Product Information [Line Items]                    
Lease term             5 years